Navigation Links
Parkinson's Drugs Tied to Compulsive Behaviors
Date:5/10/2010

Impulse control disorders noted in patients include gambling and binge eating

MONDAY, May 10 (HealthDay News) -- Medicines used to treat Parkinson's disease may increase the risk of impulse control disorders, such as problem gambling, compulsive shopping and binge eating, researchers warn.

In a new study that included 3,090 patients being treated for Parkinson's at 46 movement disorder centers in the United States and Canada, the researchers found that 13.6 percent of the patients had impulse control disorders. These impulse disorders included gambling (5 percent), compulsive sexual behavior (3.5 percent), compulsive shopping (5.7 percent) and binge eating (4.3 percent), and nearly 4 percent of the patients had two or more of these disorders.

Impulse control disorders were more common among patients taking dopamine agonist medications (17.1 percent) than in those not taking the drugs (6.9 percent), the study authors found. Other factors associated with impulse control disorders were: use of levodopa (another treatment for Parkinson's); living in the United States; being younger or unmarried; smoking cigarettes; and having a family history of gambling problems.

"Dopamine agonist treatment in Parkinson's disease is associated with 2- to 3.5-fold increased odds of having an impulse control disorder," wrote Dr. Daniel Weintraub, of the University of Pennsylvania, Philadelphia, and Philadelphia VA Medical Center, and colleagues. "This association represents a drug class relationship across impulse control disorders. The association of other demographic and clinical variables with impulse control disorders suggests a complex relationship that requires additional investigation to optimize prevention and treatment strategies."

The researchers noted that dopamine agonists are increasingly being used to treat other conditions, such as fibromyalgia and restless legs syndrome.

"Larger . . . studies in these other populations are needed to examine the possible relationships between dopamine agonist treatment, other clinical features and impulse control disorders," the authors concluded.

The study is published in the May issue of the journal Archives of Neurology.

More information

The Parkinson's Disease Foundation has more about Parkinson's disease patients and impulse control problems.



-- Robert Preidt



SOURCE: JAMA/Archives journals, news release, May 10, 2010


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Stomach Acid Drugs Come with Dangers, Studies Show
2. Anemia Drugs Hold Dangers for Kidney Patients
3. As FDA Eyes Prostate Cancer Drugs, Experts Urge Caution
4. Taking Flu Drugs While Pregnant Appears to Be Safe: Study
5. OTC Drugs May Work Differently in Obese Kids
6. Study finds that drugs used for treatment of influenza in pregnancy appear to be safe
7. BATTLE links potential biomarkers to drugs for lung cancer
8. Matching Tumor Types to Drugs Boosts Lung Cancer Outcomes
9. Cholesterol Drugs May Slow MS
10. Real Men Don't Take Erectile Dysfunction Drugs Without a Prescription
11. Poisoning by prescription drugs on the rise
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2017)... ... ... Medic CE , a Career Step company, is sponsoring a live, 1-hour ... Journal of Emergency Medical Services (JEMS). The free webinar, to be held on Wednesday, ... Duckworth, LP, a career fire captain as well as founder and director of the ...
(Date:5/24/2017)... ... , ... If you are thinking of a visit to San Francisco , fall is ... perfect time to visit. , Business Architecture Associates is pleased to offer 5 days of ... a 4-½ day package for individuals, and as 4-½ day corporate package for up to ...
(Date:5/24/2017)... ... ... Rob Lowe is a sought after actor, and also serves as the host ... topics from all aspects of life, and a new segment is being developed on ... , Podiatry is essential to people’s overall well-being, and if viewers have feet problems, ...
(Date:5/24/2017)... ... May 24, 2017 , ... Fiberstar, Inc., ... the food and beverage industry offers Citri-Fi®, a natural citrus fiber, to improve ... decision process. As a result, labels need to deliver simple, transparent and clear ...
(Date:5/24/2017)... MN (PRWEB) , ... May 24, 2017 , ... ... of polyvinylidene fluoride (PVDF) based sleep diagnostics sensors, announced today it had completed ... now consists of a mix of domestic and rest of world (ROW) authorized ...
Breaking Medicine News(10 mins):
(Date:5/8/2017)... 2017  Diplomat Pharmacy, Inc. (NYSE: DPLO)., has completed ... a health care service center company based in ... in relationship management programs for leading pharmaceutical manufacturers and ... WRB will join Envoy Health Management, LLC ... manufacturers, biotech firms, and other service companies. Together, WRB ...
(Date:5/4/2017)... , May 4, 2017  A recent ... Control, Ultraviolet-C light as a means ... SmartUVC,s ability to reduce bioburden on anesthesia workstations. ... reduction on high-touch, complex medical equipment surfaces contaminated ... infections. "This study further validates the ...
(Date:5/4/2017)... Wash. , May 4, 2017   BioLife ... leading developer, manufacturer and marketer of proprietary clinical grade ... media ("BioLife" or the "Company"), today announced that the ... after market close on Thursday, May 11, 2017, and ... live webcast at 1:30 p.m. PT that afternoon. Management ...
Breaking Medicine Technology: